Publications by authors named "Maria Ester Ruiz-Lucea"
Article Synopsis
- The study aims to evaluate how different targeted therapies and other factors impact COVID-19 hospitalisation risk in patients with inflammatory rheumatic diseases.
- A cohort of 7,782 patients was analyzed, revealing that while most targeted therapies weren't linked to increased hospitalisation risk, TNF inhibitors significantly lowered it, while rituximab appeared to increase risk.
- Key demographics and comorbidities, alongside COVID-19 symptoms, also influenced hospitalisation likelihood, indicating that multiple factors play a role in patient outcomes.
